Panel Discussion

Sessions

1. 

   Michael Bales

   

   10:50 AM – 11:35 AM

   ​​From pilot to scale: how life-science companies can achieve AI companywide adoption to support commercial activities

   • Hear how Life Science companies should approach compliant and sustainable AI adoption.
   • ‍From AI pilots, to Centres of Excellence & strategic partnerships; discover what has delivered the most value to date.
   • Learn from commercial leaders on their strategic AI focus for 2024 and beyond, emphasizing AI-driven efficiency, personalization, digital innovations and the importance of ethical use in AI.

   ‍

   • Michael Bales, Director, Strategy & Commercial Operations , Merck Canada

   • Alyssa Lefaivre Škopac, Head of Global Partnerships and Growth, Responsible AI Institute

   • Rahul Rani,, Commercial Capabilities Project Manager, GSK

   • Aletta Brandle, Team Lead, Omnichannel Excellence, Boehringer Ingelheim

   • Chris Weber, Head of Customer Experience , Takeda

   • Panel Discussion

2. 

   Neil Follett

   

   1:10 PM – 1:55 PM

   The AI-powered agency: the benefits and risks clients must consider with this new agency model

   • Hear from leading agencies on the possibilities towards increasing value through generative AI capabilities.
   • Learn how Gen AI may be deployed for pharma marketing and communication campaigns.
   • Understand the risks and benefits before procuring an “AI-powered” agency

   • Neil Follett, Co-Founder & Strategic Advisor , PharmaBrands

   • Dave Makerewich, Founder, Maven

   • David Churchill, Vice President, Healthcare Business Strategy, Lemieux Bédard Communications.

   • Brad Breininger, EVP, Strategy, Believeco:Partners

   • Panel Discussion